The Immune Response to Stroke
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Oslo
About this trial
Some patients develop cognitive decline after a stroke, but we don't always understand the mechanisms. It has been proposed that a proportion of the patients develop an autoimmune immune response, and that this could potentially explain the cognitive decline in some of the patients. The current study aims to investigate this hypothesis in a subgroup of patients with stroke.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Stroke < 72 h
Age > 18 years
Disqualifiers
Brain hemorrhage verified by CT or MRI scan
Previous or present immunological disease or other serious comorbidity
Ongoing immune respons after infection or vaccination < 1 month
Cognitive without ability to understand and/or give an informed consent to participate in the study
Trial population
Patients suffering from acute cerebral infarction
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Analysis of post-stroke immune responses
Other interventionAnalysis of immune responses in peripheral blood
Treatment groups
40 Participants
are divided into 1 treatment groupGroup A: Stroke patients1 intervention
Trial outcomes
Primary outcomes
1
The B cell and T cell response in peripheral blood
Time frame
1 day (subject inclusion)Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Akershus University HospitalRecruiting Lørenskog
Norway
NorwaySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov